|
|
Blood, 15 May 2006, Vol. 107, No. 10, pp. 3925-3932.
Prepublished online as a Blood First Edition Paper on January 17, 2006; DOI 10.1182/blood-2005-11-4502.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Activated CD4+CD25+ T cells selectively kill B lymphocytes
Dong-Mei Zhao,
Angela M. Thornton,
Richard J. DiPaolo, and
Ethan M. Shevach
From the Laboratory of Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD.
The suppressive capacity of naturally occurring mouse CD4+CD25+ T cells on T-cell activation has been well documented. The present study is focused on the interaction of CD4+CD25+ T cells and B cells. By coculturing preactivated CD4+CD25+ T cells with B cells in the presence of polyclonal B-cell activators, we found that B-cell proliferation was significantly suppressed. The suppression of B-cell proliferation was due to increased cell death caused by the CD4+CD25+ T cells in a cell-contactdependent manner. The induction of B-cell death is not mediated by FasFas ligand pathway, but surprisingly, depends on the up-regulation of perforin and granzymes in the CD4+CD25+ T cells. Furthermore, activated CD4+CD25+ T cells preferentially killed antigen-presenting but not bystander B cells. Our results demonstrate that CD4+CD25+ T cells can act directly on B cells and suggest that the prevention of autoimmunity by CD4+CD25+ T cells can be explained, at least in part, by the direct regulation of B-cell function.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Tregs control B-cell life and death
- James J. Campbell
Blood 2006 107: 3818-3819.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
D. Zhao, C. Zhang, T. Yi, C.-L. Lin, I. Todorov, F. Kandeel, S. Forman, and D. Zeng
In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease
Blood,
September 1, 2008;
112(5):
2129 - 2138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Carvalho-Gaspar, N. D. Jones, S. Luo, L. Martin, M. O. Brook, and K. J. Wood
Location and Time-Dependent Control of Rejection by Regulatory T Cells Culminates in a Failure to Generate Memory T Cells
J. Immunol.,
May 15, 2008;
180(10):
6640 - 6648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Piconese, B. Valzasina, and M. P. Colombo
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
J. Exp. Med.,
April 14, 2008;
205(4):
825 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Scabeni, M. Lapilla, S. Musio, B. Gallo, E. Ciusani, L. Steinman, R. Mantegazza, and R. Pedotti
CD4+CD25+ Regulatory T Cells Specific for a Thymus-Expressed Antigen Prevent the Development of Anaphylaxis to Self
J. Immunol.,
April 1, 2008;
180(7):
4433 - 4440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tzankov, C. Meier, P. Hirschmann, P. Went, S. A. Pileri, and S. Dirnhofer
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Haematologica,
February 1, 2008;
93(2):
193 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. DiPaolo, C. Brinster, T. S. Davidson, J. Andersson, D. Glass, and E. M. Shevach
Autoantigen-Specific TGFbeta-Induced Foxp3+ Regulatory T Cells Prevent Autoimmunity by Inhibiting Dendritic Cells from Activating Autoreactive T Cells
J. Immunol.,
October 1, 2007;
179(7):
4685 - 4693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Moens, A. Jeurissen, R. S. Mittler, G. Wuyts, G. Michiels, L. Boon, J. L. Ceuppens, and X. Bossuyt
Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae
J. Leukoc. Biol.,
September 1, 2007;
82(3):
638 - 644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Herve, I. Isnardi, Y.-s. Ng, J. B. Bussel, H. D. Ochs, C. Cunningham-Rundles, and E. Meffre
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance
J. Exp. Med.,
July 9, 2007;
204(7):
1583 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Yakirevich and M. B. Resnick
Regulatory T Lymphocytes: Pivotal Components of the Host Antitumor Response
J. Clin. Oncol.,
June 20, 2007;
25(18):
2506 - 2508.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Guay, J. Larkin III, C. C. Picca, L. Panarey, and A. J. Caton
Spontaneous Autoreactive Memory B Cell Formation Driven by a High Frequency of Autoreactive CD4+ T Cells
J. Immunol.,
April 15, 2007;
178(8):
4793 - 4802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Haribhai, W. Lin, L. M. Relland, N. Truong, C. B. Williams, and T. A. Chatila
Regulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen
J. Immunol.,
March 1, 2007;
178(5):
2961 - 2972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zeiser, V. H. Nguyen, J.-Z. Hou, A. Beilhack, E. Zambricki, M. Buess, C. H. Contag, and R. S. Negrin
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Blood,
March 1, 2007;
109(5):
2225 - 2233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Callaghan, F. J. Rouhani, M. C. Negus, A. J. Curry, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew
Abrogation of Antibody-Mediated Allograft Rejection by Regulatory CD4 T Cells with Indirect Allospecificity
J. Immunol.,
February 15, 2007;
178(4):
2221 - 2228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kotner and R. Tarleton
Endogenous CD4+ CD25+ Regulatory T Cells Have a Limited Role in the Control of Trypanosoma cruzi Infection in Mice
Infect. Immun.,
February 1, 2007;
75(2):
861 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ralainirina, A. Poli, T. Michel, L. Poos, E. Andres, F. Hentges, and J. Zimmer
Control of NK cell functions by CD4+CD25+ regulatory T cells
J. Leukoc. Biol.,
January 1, 2007;
81(1):
144 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Venet, A. Pachot, A.-L. Debard, J. Bohe, J. Bienvenu, A. Lepape, W. S. Powell, and G. Monneret
Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism
J. Immunol.,
November 1, 2006;
177(9):
6540 - 6547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Carreras, A. Lopez-Guillermo, B. C. Fox, L. Colomo, A. Martinez, G. Roncador, E. Montserrat, E. Campo, and A. H. Banham
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Blood,
November 1, 2006;
108(9):
2957 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Wing, Z. Fehervari, and S. Sakaguchi
Emerging possibilities in the development and function of regulatory T cells
Int. Immunol.,
July 1, 2006;
18(7):
991 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |